Literature DB >> 3789622

Mastalgia; is this commonly associated with operable breast cancer?

J A Smallwood, D A Kye, I Taylor.   

Abstract

A detailed analysis by questionnaire of breast pain in 460 newly referred patients at a specialized breast clinic revealed that only 1.5% of patients with pain had an early breast cancer. Of all 44 cancers 8 were painful but only 4 considered early. All these had nipple retraction. We conclude that although breast pain is rarely associated with cancer, localized pain must be fully investigated to exclude this diagnosis.

Entities:  

Mesh:

Year:  1986        PMID: 3789622      PMCID: PMC2498340     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  3 in total

1.  Carcinoma of the breast; the diagnostic significance of pain.

Authors:  L RIVER; J SILVERSTEIN; J GROUT; E NICHOLAS; A SCHAIRER; B CARLSON; R TANOUE; J TOPE
Journal:  Am J Surg       Date:  1951-12       Impact factor: 2.565

2.  The operative management of subclinical breast cancer.

Authors:  P E Preece; I H Gravelle; L E Hughes; M Baum; R W Fortt; J G Leopold
Journal:  Clin Oncol       Date:  1977-06

3.  Importance of mastalgia in operable breast cancer.

Authors:  P E Preece; M Baum; R E Mansel; D J Webster; R W Fortt; I H Gravelle; L E Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01
  3 in total
  3 in total

1.  Breast clinic referrals: can mastalgia be managed in primary care?

Authors:  D P Joyce; J Alamiri; A J Lowery; E Downey; A Ahmed; R McLaughlin; A D K Hill
Journal:  Ir J Med Sci       Date:  2014-01-09       Impact factor: 1.568

2.  Factors Effecting Mastalgia.

Authors:  Tunc Eren; Adem Aslan; Ibrahim A Ozemir; Hakan Baysal; Julide Sagiroglu; Ozgur Ekinci; Orhan Alimoglu
Journal:  Breast Care (Basel)       Date:  2016-03-29       Impact factor: 2.860

3.  Sleep disturbances and non-cyclical breast pain: where to break the vicious cycle?

Authors:  Pelin Basım; Sena Tolu
Journal:  Sleep Breath       Date:  2021-05-25       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.